ENVALITH
群栄化学工業株式会社 logo

Gun Ei Chemical Industry Co.,Ltd.

4229・Prime Market・Chemicals

Official website
群栄化学工業株式会社 logo
Gun Ei Chemical Industry Co.,Ltd.4229

Business

Gun Ei Chemical Industry, founded in 1946, is listed on the Prime Market of the Tokyo Stock Exchange. In its Chemicals Business (approximately 85% of sales), the company manufactures and sells industrial and special phenolic resins under the brands "Resitop" and "Millex", resins for electronic materials, the high-performance phenolic resin fiber "Kynol", and binders for foundry use, among other products. In addition to its domestic Takasaki and Shiga plants, the company has overseas subsidiaries in Thailand, India, and the United States, supplying customers in the semiconductor, electronic materials, automotive, and environmental fields. In its Food Business (approximately 15%), the company sells starch sugars such as isomerized sugar, glucose, and oligosaccharides to domestic food and beverage manufacturers. The Real Estate Utilization Business supplements stable earnings through the leasing of company-owned real estate.

Business Model

In the Chemicals Business, leveraging its proprietary molecular design and low-metal-content technologies as a core strength, the company develops and manufactures resins for electronic materials used in semiconductor front-end and back-end processes, as well as environmentally friendly materials, selling them directly to customers in Japan and overseas. It employs a build-to-forecast production model, maintaining a stable supply system while managing inventory risk. The Food Business captures domestic demand through the manufacture and sale of starch sugars, while Real Estate Leasing (operating margin of 62.8%) supplements stable cash flow, forming a three-segment structure that diversifies earnings across multiple layers.

Company Strengths

The Company offers Resin for Electronic Materials, which holds a large market share as a photoresist raw material. Expanded production facilities came online in FY2024, and a new plant scheduled to start operations in FY2026 is currently under construction. The Company continues to deepen its accumulated molecular design and low-metal-content technologies, driving ongoing development of new products for both front-end and back-end semiconductor processes.

Kynol is a high-performance phenolic resin fiber characterized by high specific surface area, fiber strength, and uniform pore structure, with growing demand in solvent recovery and environmental purification applications. Expanded production facilities began operating in FY2025, supporting increased supply capacity backed by the Company's proprietary manufacturing technology.

Group R&D expenses for FY2026 (ending March 2026) totaled ¥1,427 million (of which ¥1,405 million was attributable to the Chemicals Business). The ratio of new product sales (products launched within the past five years) stood at 10%. The Company also engages in industry-government-academia collaboration and joint development with Takasaki City, and has built a track record of commercializing technology seeds, such as the cosmetic ingredient HAGmi, which has been adopted by multiple companies.

ENVALITH's Perspective

The company has left its consolidated earnings forecast and dividend forecast for FY2027 (ending March 2026) undetermined, citing the difficulty of reasonably estimating the impact of the Middle East situation on raw material prices and procurement. The Chemicals Business is highly dependent on petrochemical-based raw materials, and rising raw material costs stemming from geopolitical risk could directly hit profit margins. For investors, the lack of visibility into earnings is a source of uncertainty in share valuation, and the timing and content of the forecast announcement will be a near-term share price catalyst.

The Chemicals Business accounts for approximately 93% of consolidated operating profit, and within it, the weighting of resins for electronic materials applications continues to rise. As long as external tailwinds from generative AI and memory demand persist, this supports earnings, but there is a risk that the impact on performance could become significant in a downturn in the semiconductor market. In FY2026 (ending March 2026), High-Performance Fiber (Kynol) for environmental applications has been sluggish due to inventory adjustments in China, and the concentration risk in terms of application and region continues to warrant close attention.

In the Food Business, despite efforts to correct profitability in FY2026 (ending March 2026), with net sales of ¥4,564 million (down 5.7% year on year) and segment profit of ¥35 million (operating profit margin of 0.8%), profitability remains extremely low. Sales have been pushed down by a decline in sales volume resulting from a review of the product portfolio, and the trade-off between scale reduction and profitability improvement continues. Whether the creation of new businesses in "high-function sugar chemicals," as set out in the medium-term management policy, leads to a fundamental improvement in the profitability of the Food Business will be a key point of evaluation over the medium to long term.

Growth Strategy

Under the GCI Group Medium-Term Management Policy 2030, the company is pursuing transformation across three pillars: high-purity advanced materials, environmental response, and high-performance sugar chemicals.

To meet growing demand for phenolic resin used as a raw material for semiconductor photoresists, the company is making capital investments in capacity expansion facilities (operational from FY2024) and a new plant (scheduled to start operations in FY2025). Acquisition of tangible fixed assets in FY2026 (ending March 2026) rose sharply to ¥5,173 million from ¥2,951 million in the previous fiscal year, indicating that the investment cycle is now in full swing.

The company is developing capacity expansion facilities for High-Performance Fiber used in solvent recovery and environment-related applications, scheduled to start operations in FY2025. In FY2026 (ending March 2026), performance was subdued due to inventory adjustments in China, but the company aims to capture medium- to long-term demand, with tightening environmental regulations expected to serve as a tailwind. This is a core initiative within the "Environmentally Responsive Chemicals" domain.

Through investment in its Indian subsidiary, the company is doubling production capacity to capture growing chemical product demand in the rapidly expanding Indian market. Cost reduction at overseas subsidiaries is also being pursued in parallel. In FY2026 (ending March 2026), profit contribution from the subsidiary contributed to an increase in Chemicals Business segment profit (up 13.3% year on year).

As part of "New Business Creation (High-Performance Sugar Chemicals)" set forth in the "GCI Group Medium-Term Management Policy 2030," the company is advancing functional evaluation and market development of proprietary products that combine sugar and chemical technologies. The aim is to fundamentally improve profitability of the Food Business and establish a new growth pillar, but as of FY2026 (ending March 2026), both sales and profit in the Food Business remain at low levels, and progress toward commercialization remains limited.

The company's basic policy is to strengthen its financial position with awareness of capital costs while balancing shareholder returns, aiming for stable dividends with a payout ratio target of around 40%. In FY2026 (ending March 2026), the company paid an annual dividend of ¥100 per share (interim ¥50, year-end ¥50), resulting in a payout ratio of 33.6%. The dividend forecast for FY2027 (ending March 2026) remains undetermined at this time, as earnings forecasts have not yet been set.

Last updated: July 19, 2026